4.3 Article

To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study

期刊

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00228-021-03146-5

关键词

Warfarin; Gene polymorphism; VKORC1; Model

资金

  1. Natural Science Foundation of Fujian Province, China [2018Y0037]

向作者/读者索取更多资源

This study systematically investigated genetic and non-genetic factors affecting warfarin dose in the Chinese Han population. The pharmacogenomic dose prediction model constructed in this study can predict the anticoagulant efficacy of warfarin and has potential application value in clinical practice.
Purpose The purpose of this paper is to study the correlation between demographic and clinical factors and warfarin dose of patients in Chinese Han population taking warfarin and study gene polymorphisms impact of related gene loci (CYP2C9*3, VKORC1-1639G > A) on warfarin doses, to establish a model to predict initial standard dose and maintenance dose based on CYP2C9*3, VKORC1-1639G > A genotype. Methods The study collects the data of patients in our hospital and other subcenters which incorporates 2160 patients to establish the initial dose model and 1698 patients for the stable dose model, and sequences 26 multigene sites in 451 patients. Based on the patient's dosage, clinical data, and demographic characteristics, the genetic and non-genetic effects on the initial dose and stable dose of warfarin are calculated by using statistical methods, and the prediction model of initial standard dose and maintenance dose can be established via multiple linear regression. Results The initial dose of warfarin (mg/day) was calculated as (1.346 + 0.350 x (VKORC1-1639G > A) - 0.273 x (CYP2C9*3) + 0.245 x (body surface area) - 0.003 x (age) - 0.036 x (amine-iodine) + 0.021 x (sex))(2). This model incorporated seven factors and explained 55.3% of the individualization differences of the warfarin drug dose. The maintenance dose of warfarin (mg/day) was calculated as (1.336 + 0.299 x (VKORC1-1639G > A) + 0.480 x (body surface area) - 0.214 x (CYP2C9*3) - 0.074 x (amine-iodine) - 0.003 x (age) - 0.077 x (statins) - 0.002 x (height))(2). This model incorporated six factors and explained 42.4% of the individualization differences in the warfarin drug dose. Conclusion The genetic and non-genetic factors affecting warfarin dose in Chinese Han population were studied systematically in this study. The pharmacogenomic dose prediction model constructed in this study can predict anticoagulant efficacy of warfarin and has potential application value in clinical practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据